Black Friday Sale - Ends Soon!
-35% Off Everything
Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$468.10.8%
Market Cap$124.0B
Financial ratios score
10/10
Revenue growth
10.2%
Industry median: 6.1%
Net income growth
9.0%
Industry median: (29.0%)
Free cash flow margin
33.3%
Industry median: (222.2%)
Net Debt / EBITDA
(2.6x)
Industry median: 1.0x
ROIC
18.9%
Industry median: (39.5%)
VRTX Growth
Crunching data... Almost there!
VRTX Profitability
Crunching data... Almost there!
VRTX Bankruptcy probability
Crunching data... Almost there!
VRTX Returns on capital
Crunching data... Almost there!
Discover more VRTX fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
Is Vertex Pharmaceuticals Incorporated (VRTX) going bankrupt?
As of today, Vertex Pharmaceuticals Incorporated has a low bankruptcy probability due to healthy solvency ratios.
What is Vertex Pharmaceuticals Incorporated (VRTX) ROIC?
As of today, Vertex Pharmaceuticals Incorporated ROIC is 18.9%, based on the financial report for Dec 31, 2023 (Q4 2023).
Is Vertex Pharmaceuticals Incorporated (VRTX) ROIC good?
As of today, Vertex Pharmaceuticals Incorporated ROIC is 18.9%, which is higher than 15%, that is considered a good ROIC ratio.